Aspirin use for primary prevention of cardiovascular disease in older patients: a review of clinical guidelines and updated evidence

J Lewis, L Bethishou, LV Tsu - The Senior Care Pharmacist, 2019 - ingentaconnect.com
prevention studies completed between 1988 and 2005.This study found that aspirin reduced
the composite of serious vascular events … (composite of CV events) and an increased risk of …

Clopidogrel plus aspirin use is associated with worse long-term outcomes, but aspirin use alone is safe in patients with vasospastic angina: results from the VA-Korea …

SS Cho, SH Jo, SH Han, KY Lee, SH Her, MH Lee… - Scientific reports, 2019 - nature.com
… of aspirin plus clopidogrel to be an independent risk factor … , sex, history of coronary heart
disease (CHD, CHD was defined … To avoid the potential bias of selecting patients at high risk in …

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

JW Eikelboom, J Hirsh, JI Weitz, M Johnston, Q Yi… - Circulation, 2002 - Am Heart Assoc
among aspirin-treated patients at high risk of cardiovascular events, persistent thromboxane
generation predicts the risk of … Effects of clopidogrel in addition to aspirin in preventing major …

High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial

M Weber, DL Bhatt, DM Brennan, GJ Hankey… - Heart, 2011 - heart.bmj.com
… of clopidogrel plus low-dose aspirin compared with aspirin alone in patients at high risk
of a cardiovascular event… to prevent vascular events in men and women with elevated C-reactive …

Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis

S Halvorsen, F Andreotti, JM ten Berg… - … College of Cardiology, 2014 - jacc.org
… According to the ESC guidelines, aspirin or clopidogrel “is not recommended in individuals
… In people at moderate-to-high risk of cardiovascular events, the reduction in MIs is closely …

Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the …

M Pignone, MJ Alberts, JA Colwell, M Cushman… - Circulation, 2010 - Am Heart Assoc
… of cardiovascular disease (CVD) among patients with diabetes is substantial. Individuals
with diabetes are at 2- to 4-fold increased risk of cardiovascular events … such as clopidogrel. …

[HTML][HTML] Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease

EJ Armstrong, DR Anderson, KK Yeo, GD Singh… - Journal of vascular …, 2015 - Elsevier
… (DAPT) with aspirin (acetylsalicylic acid [ASA]) and clopidogrel … ) are at increased risk of
major adverse cardiovascular events (… of clopidogrel to achieve greater platelet inhibition among

Prevention of cardiovascular events in elderly people

WF Andrawes, C Bussy, J Belmin - Drugs & aging, 2005 - Springer
… drug used, this meta-analysis found a marginally greater risk reduction with diuretics and/or
β-adrenoceptor … [66,67] Aspirin, dipyridamole, ticlopidine and clopidogrel all reduce the …

[HTML][HTML] Effect of clopidogrel added to aspirin in patients with atrial fibrillation

Active Investigators - New England Journal of Medicine, 2009 - Mass Medical Soc
… of clopidogrel plus aspirin for the prevention of stroke and other vascular events in patients
with … with atrial fibrillation who were at increased risk for stroke and for whom therapy with a …

Network meta-analysis of ticagrelor for stroke prevention in patients at high risk for cardiovascular or cerebrovascular events

A Bálint, D Tornyos, O El Alaoui El Abdallaoui, P Kupó… - Stroke, 2021 - Am Heart Assoc
patients with high risk for cardiovascular or cerebrovascular disease, defined as coronary
artery disease… % lower with aspirin plus clopidogrel and 20% lower with aspirin plus ticagrelor (…